drugset / Trial / NCT06973889
Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
1. Investigating its effectiveness in removing bacteria in invivo conditions 2. Investigating the effectiveness in improving the clinical symptoms of patients
Timeline
- Start
- 2023-12-04
- Primary completion
- 2024-12-30
- Completion
- 2025-01-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IgY | Protein / enzyme biologic | 2 g | — |
| Background | Amoxicillin | Other / unclassified | 2000 mg | — |
| Background | Clarithromycin | Small molecule | 1000 mg | — |
| Background | Omeprazole | Other / unclassified | 40 mg | — |